| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/05/1993 | WO1993014770A1 Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative |
| 08/05/1993 | WO1993014767A2 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 08/05/1993 | WO1993014760A2 Methods |
| 08/05/1993 | WO1993014752A1 M. fermentans infection treatment |
| 08/05/1993 | WO1993012781A3 Creatine analogs having antiviral activity |
| 08/05/1993 | CA2129119A1 Nucleozymes |
| 08/05/1993 | CA2128896A1 Hepatitis therapeutics |
| 08/05/1993 | CA2128860A1 Novel steroid intermediates and processes for their preparation |
| 08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | CA2128535A1 A method for delaying hiv induced aids by administration of substituted azaperane compounds |
| 08/05/1993 | CA2117428A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 08/05/1993 | CA2107363A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/04/1993 | EP0554025A2 Fluorinated cyclobutyl purines and pyrimidines |
| 08/04/1993 | EP0554004A2 Cephem compounds and antibacterial agents |
| 08/04/1993 | EP0553667A1 Soluble LDL receptor, its production and use |
| 08/04/1993 | EP0553253A1 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 08/04/1993 | EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 08/04/1993 | EP0553107A1 Protein kinase c modulators with anti-inflammatory and antiviral activity |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/04/1993 | EP0351435B1 Fused pyridazine compounds and their medicinal uses |
| 08/04/1993 | EP0193586B1 ANTIGENS OF $i(PLASMODIUM FALCIPARUM) |
| 08/04/1993 | CN1074937A 4,5-dihydro geldanamycin, preparation of its hydroquinone, and applications |
| 08/04/1993 | CN1074905A Pyrrolylbenzodiazepinones |
| 08/04/1993 | CN1021735C Process for preparation of cephalosporin compounds |
| 08/03/1993 | US5232694 Canine corona virus vaccine |
| 08/03/1993 | US5232692 Administering an aqueous solution of povidone-iodine having a specified concentration to the eyes of a human infant to prevent infection by neisseria or chlamydia |
| 08/03/1993 | CA1320950C Macrolide compounds |
| 07/28/1993 | EP0552974A1 A 1-aryl-2-(1H-1,2-4-triazol-1-yl) ethanol derivative and antifungal compositions containing that derivative |
| 07/28/1993 | EP0552767A2 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use |
| 07/28/1993 | EP0552766A2 Oligonucleotide analogues, their preparation and use |
| 07/28/1993 | EP0552665A1 Pyrrolylbenzodiazepinones and medicines containing them |
| 07/28/1993 | EP0552257A1 A plant protein useful for treating tumors and hiv infection |
| 07/28/1993 | EP0552247A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 07/28/1993 | EP0528861A4 Composition and treatment with biologically active peptides and toxic cations |
| 07/28/1993 | EP0495014A4 Novel oxidized lipoproteins and methods for their preparation |
| 07/28/1993 | EP0458965A4 Process for the preparation of vinyl ethers |
| 07/28/1993 | EP0432199B1 Composition for the treatment of erectile dysfunction |
| 07/28/1993 | EP0294491B1 Antibiotic yi-hu3 and process for its preparation |
| 07/28/1993 | CA2088196A1 Fluorinated cyclobutyl purines and pyrimidines |
| 07/27/1993 | US5231024 Hybridoma cells |
| 07/27/1993 | US5231013 Staphylococcus biosynthesis |
| 07/27/1993 | CA1320730C Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| 07/25/1993 | CA2087824A1 1-aryl-2-(1h-1,2,4-triazol-1-yl) ethanol derivative and antifungal compositions containing that derivative |
| 07/25/1993 | CA2086368A1 Pyrrolylbenzodiazepinones |
| 07/22/1993 | WO1993014219A1 Marek's disease virus recombinant poxvirus vaccine |
| 07/22/1993 | WO1993014215A1 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| 07/22/1993 | WO1993014209A1 Vaccines based on streptokinase |
| 07/22/1993 | WO1993014208A2 Hepatitis e virus vaccine and method |
| 07/22/1993 | WO1993014207A1 Chimeric immunogens |
| 07/22/1993 | WO1993014206A2 Synthetic peptides for a rubella vaccine |
| 07/22/1993 | WO1993014198A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | WO1993014196A1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease |
| 07/22/1993 | WO1993014195A1 Vaccine containing acemannan as an adjuvant |
| 07/22/1993 | WO1993014194A1 Recombinant swinepox virus |
| 07/22/1993 | WO1993014190A1 Feline leukemia virus vaccines |
| 07/22/1993 | WO1993014146A1 Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process |
| 07/22/1993 | WO1993014126A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993014103A1 Therapeutic nucleosides |
| 07/22/1993 | WO1993014082A1 Pyridyl substituted imidazoles |
| 07/22/1993 | WO1993014081A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | WO1993014068A1 Novel salts of a quinolone-carboxylic acid |
| 07/22/1993 | WO1993013797A2 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
| 07/22/1993 | WO1993013793A1 Pharmaceutical bacteriocin compositions |
| 07/22/1993 | WO1993013789A1 Hemoregulatory peptides |
| 07/22/1993 | WO1993013780A1 4''-deoxyerythromycin derivatives |
| 07/22/1993 | WO1993013778A1 Therapeutic nucleosides |
| 07/22/1993 | WO1993013774A1 Methods for preventing mycobacterial infections with rifabutin |
| 07/22/1993 | WO1993013769A1 Pyropheophorbides and their use in photodynamic therapy |
| 07/22/1993 | WO1993013740A2 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | WO1993010239A3 Hepatitis-c virus testing |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/22/1993 | CA2368862A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2351694A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2314425A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2128212A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
| 07/22/1993 | CA2128211A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus |
| 07/22/1993 | CA2127991A1 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 07/22/1993 | CA2127688A1 Hemoregulatory peptides |
| 07/22/1993 | CA2127550A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | CA2127466A1 Feline leukemia virus vaccines |
| 07/22/1993 | CA2127457A1 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| 07/22/1993 | CA2127356A1 Narrow poly-and mono-dispersed anionic oligomers, and their uses, formulations and process |
| 07/22/1993 | CA2126979A1 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2125478A1 4"-deoxyerythromycin derivatives |
| 07/21/1993 | EP0552138A2 Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity |
| 07/21/1993 | EP0552137A2 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity |
| 07/21/1993 | EP0552060A1 Imidazole derivatives having anti-HIV activity |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0552018A1 Use of Rifabutin for delaying or preventing mycobacterial infections |
| 07/21/1993 | EP0551689A2 Cyclic HIV principal neutralizing determinant (PNP) peptides |
| 07/21/1993 | EP0551671A1 Treponema hyodysenteriae vaccine |
| 07/21/1993 | EP0551460A1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551428A1 Acidic polycyclic ether antibiotic |
| 07/21/1993 | EP0551308A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 07/21/1993 | EP0551304A1 Fungicidally active compounds |
| 07/21/1993 | EP0462187B1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours |